loader2
Partner With Us NRI

Vijaya Diagnostic Centre Ltd share Price Today

Company details

780.30
802.55
369.45
837.95
6M Return 28.99%
1Y Return 109.32%
Mkt Cap.(Cr) 8,032.63
Volume 396,287
Div Yield 0.13%
OI
-
OI Chg %
-
Volume 396,287

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Services company Vijaya Diagnostic Centre announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Financial Performance: reported a robust YoY revenue growth of 28.3%, with a total revenue from operations of Rs 1,552.1 million.
  • Profitability: The company observed a Profit after Tax (PAT) increase by 21.7% in Q4FY24, reaching Rs 334.5 million.
  • Operational Metrics: Vijaya Diagnostic Centre revealed operational highlights, showing a Total Tests increase of 24.1% in Q4FY24 compared to Q4FY23.

FY24 Financial Highlights:

  • Financial Performance: FY24 showed a substantial revenue increase of 19.3%, accumulating to a total of Rs 5,478.1 million in revenue from operations.
  • Profitability: The annual PAT shot up by 40.4% to Rs 1,188.3 million in FY24.

Commenting on the performance Suprita Reddy, MD & CEO said, “I'm happy to share that this quarter too maintained our strong business performance, showcasing exceptional year-over-year revenue growth of 28.3%, of which an impressive 18.5% was achieved organically. This quarter also marked a notable milestone with the wellness contributing 14% of the revenue.

After completing six months of productive business operations, our Tier II hub centre in Mahbubnagar has gained a lot of momentum and broken even in just two quarters, showing a high demand for quality diagnostics in the area, and enforcing Vijaya’s reputation as a trusted brand.

We have made significant strides toward integrating PH Pune with the parent company. With effect from April 1st, 2024, we have successfully moved all of PH's essential ERP and other IT systems to the parent company's applications. Furthermore, it gives me great pleasure to announce that we have co-branded PH as Vijaya PH.

By strategically expanding and directing our capabilities towards future opportunities, we are confident in our ability to consistently deliver lasting value to our stakeholders”

 

Result PDF

View Other Company Results

Vijaya Diagnostic Centre Ltd shares SWOT Analysis

Strengths (11)

  • Stock passes majority of CANSLIM Investment criteria
  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (3)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • Highest Recovery from 52 Week Low
  • RSI indicating price strength

Threats (2)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)

Resistance and support

R1 798.2
R2 811.5
R3 820.4
Pivot

789.23

S1 775.9
S2 767.0
S3 753.7
EMA SMA
721.0
685.2
655.5
606.3
709.2
667.3
660.8
598.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-05-10 777.46 709403 NSE
MICROCURVES TRADING PRIVATE LIMITED Bulk Purchase 2024-05-10 781.98 568215 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2024-05-10 778.51 709403 NSE
Name Category Shares
SURENDRANATH REDDY SURA PROMOTER 32.66%
SUPRITA S REDDY PROMOTER 8.97%
SUNIL CHANDRA KONDAPALLY PROMOTER 8.4%
GEETHA REDDY SURA PROMOTER 3.97%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Vijaya Diagnostic Centre Ltd Stocks COMPARISON

Financials( in Cr) Vijaya Diagnostic Centre Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Global Health Ltd Fortis Healthcare Ltd
Price 784.85 5,931.70 849.05 1,394.95 448.85
% Change -2.18 1.42 2.36 -0.43 1.16
Mcap Cr 8,032.63 85,288.95 82,520.19 37,455.38 33,886.29
Revenue TTM Cr 459.22 16,612.50 4,831.37 2,694.25 6,537.06
Net Profit TTM Cr 85.21 887.50 1,103.51 326.08 632.98
PE TTM 66.74 108.22 77.96 82.73 63.18
1 Year Return 109.32 28.23 63.31 147.97 62.54
ROCE 18.43 14.16 13.85 16.49 7.51
ROE 16.82 15.04 16.12 16.13 6.79
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 544.73 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 39,908.21 -32,861.14
LAST 3M 100,212.68 -40,336.57
LAST 6M 168,007.15 51,016.84
LAST 12M 259,938.69 133,487.81
Vijaya Diagnostic Centre Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 16, 2024 l NSE Announcement

Vijaya Diagnostic Centre Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 10, 2024 l NSE Announcement

Date Action Type Ratio
Sep 13, 2023 Dividend 100
Sep 20, 2022 Dividend 100

Vijaya Diagnostic Centre Ltd Information

Stock PE (TTM)
66.74
Promoter Holding
54.06%
Book Value
64.2132
ROCE
18.43%
ROE
16.82%
Description
  • Vijaya Diagnostic Centre Limited founded in 1981 by Dr. S. Surendranath Reddy was incorporated as Vijaya Diagnostic Centre Private Limited on 05 June 2002 as a Private Limited Company, which got subsequently, converted to a Public Limited Company and name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March 2021. The Company is the largest integrated diagnostic chain in South India, providing comprehensive, innovative and best-in-class diagnostic services, in a reliable, affordable and customer-centric manner. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations,basic and high-end radiology,nuclear medicine and related healthcare services. It has a chain of over 95 diagnostic centres spread across 15 cities that offer Laboratory Services, Radiology & Imaging Services, Cardiology Services, Neurology Services & Gastroenterology Services. Apart from these, it serves customers throughout Telangana and Andhra Pradesh with pathology and radiology services. During the FY2020,14,13,071, 0.001% Series A Compulsorily Convertible Preference Shares have been converted into 1 fully paid-up Equity Share of Rs. 10/- each and 3005, 001% Series B Compulsory Convertible Preference Shares have been converted into 3,005 fully paid up Equity Shares of Rs.10/- each. During the year 2020-21,after getting the approval of shareholders at the EGM held on 22 March 2021,the company sub-divided the face value of equity share from Rs 10 to Re 1. On 27 May 2021,the company has issued 5,66,47,736 bonus equity shares of face value Re. 1 each to its shareholders in the ratio of 5:4. The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021.

Registered Address

3-6-16&17 Street No.19, Himayatnagar, Hyderabad, Telangana, 500082

Tel : 91-40-23420411
Email : ir:vijayadiagnostic.in
Website : http://www.vijayadiagnostic.com
Registrar

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 543350
NSE Code : VIJAYA
Book Closure Date (Month) :
BSE Group : A
ISIN : INE043W01024

FAQ’s on Vijaya Diagnostic Centre Ltd Shares

You can buy (#CompanyNm) shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy (#CompanyNm) Share.

Company share prices and volatile and keep changing according to the market conditions. As of (#UpdateDate) the closing price of (#CompanyNm) was Rs.(#LTP).

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of (#UpdateDate), the market cap of (#CompanyNm) stood at Rs. (#MarketCap).

The latest PE ratio of (#CompanyNm) as of (#UpdateDate) is (#PE)

The latest PB ratio of (#CompanyNm) as of (#UpdateDate) is (#PB)

The 52-week high of (#CompanyNm) share price is Rs. (#52WeekHigh) while the 52-week low is Rs. (#52WeekLow)

According to analyst recommendations, (#CompanyNm) Share has a "(#BuyOrSell)" rating for the long term.

Download Our

Download App
market app